Close X
Monday, November 18, 2024
ADVT 
National

Magnotta first-degree murder trial hears again from forensic biologist

Darpan News Desk The Canadian Press, 15 Oct, 2014 10:41 AM

    MONTREAL - Luka Rocco Magnotta's first-degree murder trial has heard that most of the attempts at cleaning his blood-spattered apartment were poorly done.

    Magnotta is charged with first-degree murder in the slaying and dismemberment of Chinese engineering student Jun Lin in May 2012.

    Forensic biologist Jacinthe Prevost examined the apartment and other exhibits gathered at the crime scene.

    Prevost testified today she analzyed sperm stains found around the bachelor apartment and on discarded clothing in trash behind the building without finding any from Lin.

    The 32-year-old Magnotta has admitted the physical acts of which he's accused but has pleaded not guilty by way of mental disorder.

    He faces four other charges: criminally harassing Prime Minister Stephen Harper and other members of Parliament; mailing obscene and indecent material; committing an indignity to a body; and publishing obscene materials.

    Montreal homicide detective Antonio Paradiso is the Crown's next witness on Wednesday.

    MORE National ARTICLES

    DFO mapping ocean floor of B.C. to prep for potential tanker spills

    DFO mapping ocean floor of B.C. to prep for potential tanker spills
    VANCOUVER - Fisheries and Oceans Canada is looking for someone to map the ocean floor near the British Columbia coast, an area it says could be affected by spills with the expected increase in tanker traffic.

    DFO mapping ocean floor of B.C. to prep for potential tanker spills

    NATO approves new rapid response force aimed at deterring Russian aggression

    NATO approves new rapid response force aimed at deterring Russian aggression
    NEWPORT, Wales - Seeking to counter Russian aggression, NATO leaders approved plans Friday to create a rapid response force with a headquarters in Eastern Europe that could quickly mobilize if an alliance country in the region were to come under attack.

    NATO approves new rapid response force aimed at deterring Russian aggression

    Tony Accurso says he helped former Montreal police chief after failed election bid

    Tony Accurso says he helped former Montreal police chief after failed election bid
    MONTREAL - Former construction magnate Tony Accurso says he gave $250,000 to help Jacques Duchesneau because the ex-Montreal police chief was in debt after a failed bid to become mayor.

    Tony Accurso says he helped former Montreal police chief after failed election bid

    Jury Selection In Luka Rocco Magnotta's Long-awaited Murder Trial Set To Begin

    Jury Selection In Luka Rocco Magnotta's Long-awaited Murder Trial Set To Begin
    MONTREAL - One of Canada's most publicized and shocking criminal cases resumes Monday when jury selection begins in the first-degree murder trial of Luka Rocco Magnotta.

    Jury Selection In Luka Rocco Magnotta's Long-awaited Murder Trial Set To Begin

    NATO Allies Deem Islamic State A Significant Threat, Agree On Coalition To Take On Militants

    NATO Allies Deem Islamic State A Significant Threat, Agree On Coalition To Take On Militants
    NEWPORT, Wales - The U.S. and 10 of its key allies agreed Friday that the Islamic State group is a significant threat to NATO countries and that they will take on the militants by squeezing their financial resources and going after them with military might.

    NATO Allies Deem Islamic State A Significant Threat, Agree On Coalition To Take On Militants

    WHO: Blood from Ebola survivors should be used to treat patients, 2 promising vaccines found

    WHO: Blood from Ebola survivors should be used to treat patients, 2 promising vaccines found
    LONDON - Desperate to restore hope amid the Ebola crisis, the World Health Organization said Friday it would accelerate the use of experimental treatments and vaccines to contain the expanding epidemic in West Africa.

    WHO: Blood from Ebola survivors should be used to treat patients, 2 promising vaccines found